<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01568671</url>
  </required_header>
  <id_info>
    <org_study_id>120097</org_study_id>
    <secondary_id>12-DK-0097</secondary_id>
    <nct_id>NCT01568671</nct_id>
  </id_info>
  <brief_title>Energy Expenditure Responses to Different Temperatures</brief_title>
  <official_title>Energy Expenditure Responses to Different Temperatures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Background:

      - The way that the body burns calories is known as energy expenditure. Some studies show that
      when we are cold, we burn more calories to keep our bodies warm. Brown fat is a special kind
      of fat that can use energy to keep the body warm. Small animals and infants have been known
      to have brown fat for many years. Recently, it has been suggested that adult humans also have
      brown fat. If brown fat becomes active (burns calories) in adult humans when exposed to cold,
      then these people would tend to burn off more calories and might not gain weight easily.
      Learning more about the relationship between energy expenditure, brown fat, environmental
      temperature, and body temperature may help explain why some people become obese and other
      people do not.

      Objectives:

        -  To better understand how the body burns calories when exposed to different temperatures.

        -  To study brown fat and how it burns calories in cold temperatures.

      Eligibility:

        -  Healthy men between 18 and 35 or 55 and 75 years of age.

        -  Healthy women between 18 and 35 years of age.

        -  To control for ethnicity, participants must be non-Hispanic whites or African Americans.

      Design:

        -  Participants will be screened with a physical exam and medical history. Blood and urine
           samples will be collected.

        -  Participants will stay in the Metabolic Unit of the National Institutes of Health
           Clinical Center as inpatients for no more than 14 days. The length of the hospital stay
           will depend on how participants respond to the different study temperatures.

        -  Every afternoon, participants will walk for 30 minutes on a treadmill. All meals will be
           provided.

        -  Participants will stay up to 5 hours per day in a specialized room with different
           temperature settings. Temperatures will range from about 61 degrees to 88 degrees
           Fahrenheit. Body temperature, activity, calorie burning, and cold/hot sensations will be
           monitored. On the study day of the coldest temperature, participants will have an
           imaging study to look for brown fat activity.

        -  Participants will be compensated for their time and participation at the end of the
           study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surprisingly little is understood about how the body regulates heat production (energy
      expenditure, EE) in response to subtle changes in environmental temperature. For example,
      only recently has it been realized that brown adipose tissue is functional in adult humans.
      It is plausible that the mechanisms governing heat production contribute to regulation of
      body weight and thus may be contributing to the current obesity epidemic: even small changes
      in EE, if not compensated by changes in food intake, can have long-term effects on body
      weight.

      The thermoneutral zone (TNZ) is the environmental temperature range over which EE is at a
      minimum and does not change with environmental temperature. The lower and upper critical
      temperatures define the temperature limits of the TNZ. At environmental temperatures below
      the lower critical temperature, the EE vs. environmental temperature graph is reported to be
      a straight line with the extrapolated X-axis intercept being the defended body temperature.
      Some of these parameters are predicted to be different for obese as compared to lean
      individuals. With the global obesity epidemic coinciding with improved indoor temperature
      control, a better understanding of the relationship between EE and thermoregulation is
      desirable.

      This protocol has three phases. The first is a pilot in lean males to optimize procedures and
      establish the feasibility, sensitivity, and behavior of the assays. Second, lean and obese
      male cohorts will be compared to ensure that the expected differences can be observed. Third,
      additional variables will be examined, such as age, race, sex, and menstrual phase in women.

      Specifically, we will map the resting EE response to environmental temperatures from 16-31
      degrees Celsius during inpatient stays in the NIH Metabolic Clinical Research Unit. Each day
      resting EE will be measured in a room respiration calorimeter with a different environmental
      temperature (subjects will be blinded as to room temperature). The remainder of each study
      day will be spent at 23-25 degrees Celsius in the individual patient room.

      Standard diet and physical activity will be maintained and body weight will be held stable.
      Additionally core body and skin temperatures, heart rate and variability, muscle activity by
      surface electromyography, and thermal comfort and hunger using visual analog scales will be
      measured.

      This study will establish techniques and provide baseline normative data, allowing insight
      into the mechanisms regulating the EE in humans and how these are affected by obesity. It is
      envisioned that this study will provide the basis for investigation of the effects of acute
      and chronic weight change and the effects of drug therapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 14, 2012</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Resting, energy expenditure, heat production, heat loss, thermal neutral zone, environmental temperature, obesity.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age, sex, race, body temperature, brown adipose tissue, shivering, sweating, hunger, comfort.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Healthy</condition>
  <condition>Obese</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

          -  Generally healthy.

          -  Males between the age greater than or equal to 18 -35 years or between 55-75 years,
             male orand females between the age 18-35 years.

          -  Self-reported non-Hispanic and non-Latino Caucasian and African-Americans

          -  Written informed consent.

        EXCLUSION CRITERIA:

          -  Hypo- or hyper-thyroid (history or TSH &gt;5.0&lt;0.4 miU/L)

          -  Psychological conditions,such as (but not limited to) claustrophobia, clinical
             depression, bipolar disorders, that would be incompatible with safe and successful
             participation in this study

          -  Weight change &gt;5% in the past 6 months or a trained athlete

        Blood pressure greater than 140/90 mmHg or current antihypertensive therapy

          -  History of cardiovascular disease

          -  BMI &lt;18.5, between 25.1-29.9, and &gt;40 Kg/m(2)

          -  Diabetes mellitus (fasting serum glucose &gt; 126 mg/dL)

          -  Liver disease or ALT serum level greater than two times the laboratory upper limit of
             normal

          -  Iron deficiency (Ferritin &lt; 30 mcg/L males, &lt; 15 mcg/L females)

          -  Abnormal kidney function (eGFR&lt;60 ml/min/1.73m(2))

          -  History of illicit drug or alcohol abuse within the last 5 years; current use of drugs
             (by history) or alcohol (CAGE greater than or equal to 2)

          -  Current use of medications/dietary supplements/alternative therapies known to alter
             energy metabolism

          -  Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year

          -  Perimenopausal (as self-described within two years from onset of amenorrhea or current
             complaints of hot flashes)

          -  For pre-menopausal women, irregular periods or polycystic ovarian disease

          -  Current smoker or user of tobacco products

          -  Metal implant that prevents subject from being in a MRI scanner.

        All subjects will be fully informed of the aims, nature, and risks of the study prior to
        giving written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kong Y Chen, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margaret S McGehee, C.R.N.P.</last_name>
    <phone>(301) 594-6799</phone>
    <email>mcgeheems@mail.nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kong Y Chen, Ph.D.</last_name>
    <phone>(301) 451-1636</phone>
    <email>chenkong@niddk.nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)</last_name>
      <phone>800-411-1222</phone>
      <phone_ext>TTY8664111010</phone_ext>
      <email>prpl@cc.nih.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2012-DK-0097.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E444-52. Epub 2007 May 1. Review.</citation>
    <PMID>17473055</PMID>
  </reference>
  <reference>
    <citation>Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerb√§ck S, Nuutila P. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009 Apr 9;360(15):1518-25. doi: 10.1056/NEJMoa0808949. Erratum in: N Engl J Med. 2009 Sep 10;361(11):1123.</citation>
    <PMID>19357407</PMID>
  </reference>
  <reference>
    <citation>van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009 Apr 9;360(15):1500-8. doi: 10.1056/NEJMoa0808718. Erratum in: N Engl J Med. 2009 Apr 30;360(18):1917.</citation>
    <PMID>19357405</PMID>
  </reference>
  <verification_date>April 24, 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2012</study_first_submitted>
  <study_first_submitted_qc>March 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2012</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adult</keyword>
  <keyword>Body Fat Distribution</keyword>
  <keyword>Healthy</keyword>
  <keyword>Metabolic Rate</keyword>
  <keyword>Thermophysiology</keyword>
  <keyword>Brown Fat</keyword>
  <keyword>Healthy Volunteer</keyword>
  <keyword>HV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

